This is a StreetInsider.com Premium Only Page

Brickell Biotech (BBI) – Management Comments

Oct 7, 2021 06:56 AM Brickell Biotech (BBI) Achieves Statistical Significance on all Primary, Secondary Endpoints from Both U.S. Phase 3 Pivotal Studies of Sofpironium Bromide Gel, 15% in Primary Axillary Hyperhidrosis

Apr 27, 2021 07:36 AM Brickell Biotech (BBI) Reports Complete Patient Enrollment in U.S. Phase 3 Pivotal Cardigan I Study of Sofpironium Bromide Gel

Jan 19, 2021 07:06 AM

Dec 7, 2020 07:33 AM

Oct 6, 2020 07:08 AM

Sep 8, 2020 07:36 AM

Jun 15, 2020 06:32 AM

Feb 20, 2020 06:52 AM